These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma. Kuo P; Manes RP; Schwam ZG; Judson BL Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092 [TBL] [Abstract][Full Text] [Related]
5. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience. Bhasker S; Mallick S; Benson R; Bhanuprasad V; Sharma A; Thakar A J Laryngol Otol; 2017 Jan; 131(1):19-25. PubMed ID: 27938440 [TBL] [Abstract][Full Text] [Related]
6. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience. Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906 [TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma. Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826 [TBL] [Abstract][Full Text] [Related]
8. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature. Zielinski V; Laban S; Tribius S; Schafhausen P; Veldhoen S; Knecht R; Clauditz T; Muenscher A Ear Nose Throat J; 2016 Jan; 95(1):23-8. PubMed ID: 26829682 [TBL] [Abstract][Full Text] [Related]
9. Pre-operative chemoradiation for sinonasal undifferentiated carcinoma of the anterior nasal cavity resected through a lateral nasal flap approach. Surapaneni B; Kadakia S; Slupchynskyj O; Iacob C; Holliday R Am J Otolaryngol; 2016; 37(2):120-4. PubMed ID: 26954865 [TBL] [Abstract][Full Text] [Related]
10. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers. Bell D; Hanna EY Expert Rev Anticancer Ther; 2013 Mar; 13(3):285-96. PubMed ID: 23477516 [TBL] [Abstract][Full Text] [Related]
12. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck. Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024 [TBL] [Abstract][Full Text] [Related]
13. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis. Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819 [TBL] [Abstract][Full Text] [Related]
14. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621 [TBL] [Abstract][Full Text] [Related]
15. Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Al-Mamgani A; van Rooij P; Mehilal R; Tans L; Levendag PC Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):293-9. PubMed ID: 22476411 [TBL] [Abstract][Full Text] [Related]
16. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature. Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722 [TBL] [Abstract][Full Text] [Related]
17. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549 [TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248 [TBL] [Abstract][Full Text] [Related]
19. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472 [TBL] [Abstract][Full Text] [Related]
20. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Chen AM; Daly ME; El-Sayed I; Garcia J; Lee NY; Bucci MK; Kaplan MJ Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):338-43. PubMed ID: 18207030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]